Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View All
Indianapolis Business Journal mentions Regenstrief Institute with other high profile partners along with Indiana University, Eli Lilly
Regenstrief Institute was featured by The Daily Journal as a...
Influence
View All
Effectiveness of 2023–2024 COVID-19 vaccines in children in the U.S.
Published in Pediatrics. Here is a link to the article....
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
Partner With US - Experts